Abstract
Main text(Molecular Therapy: Nucleic Acids 12, 578-590; September 2018) This article has been retracted at the request of the editor-in-chief. In investigating concerns of image duplications initially raised on PubPeer (https://pubpeer.com/publications/4661DB0D531C610DD10E8EAD3C2D97), evidence for image duplication in identical or altered fashion in Figures 5B, 5C, and 5G, as well as image manipulation in Figures 6D and S4F, was identified. In addition, an investigation conducted by the Supervision Committee of the National Natural Science Foundation of China has concluded that this article contains forged and altered images (https://www.nsfc.gov.cn/publish/portal0/tab434/info87591.htm). This reuse and misrepresentation of data without appropriate attribution represents a severe abuse of the scientific publishing system. All authors disagree with the retraction of this article.
| Original language | English |
|---|---|
| Pages (from-to) | 378 |
| Number of pages | 1 |
| Journal | Molecular Therapy Nucleic Acids |
| Volume | 30 |
| DOIs |
|
| State | Published - Dec 13 2022 |
Fingerprint
Dive into the research topics of 'Retraction Notice to: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID (Molecular Therapy - Nucleic Acids (2018) 12 (578–590), (S2162253118301380), (10.1016/j.omtn.2018.06.011))'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver